Device
HyperSight Imaging
HyperSight Imaging is a medical device with 3 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(67%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Completed(1)
Detailed Status
Active, not recruiting2
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
completed133%
active_not_recruiting267%
Recent Activity
2 active trials
Showing 3 of 3
Clinical Trials (3)
Showing 3 of 3 trials
NCT06576908Not Applicable
Evaluation of On-Couch CBCT Image Quality
NCT06187103
Evaluation of Improved Onboard Patient Imaging
NCT05975619Not Applicable
A Prospective Imaging Study of the Integrated TrueBeam-HyperSight CBCT System
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3